#Singapore #Genesis Medtech #CE Certification #iREACH IRIS

Genesis MedTech's Reach Surgical Receives CE Certification for iREACH IRIS

Genesis MedTech has recently achieved a significant milestone with its surgical solutions division, Reach Surgical, by obtaining CE certification for its revolutionary product, iREACH IRIS. This next-generation fully motorized stapling platform is designed to provide surgeons with a cutting-edge approach that allows real-time assessment during procedures, radically changing the landscape of surgical stapling.

Introduction to iREACH IRIS

The iREACH IRIS stands out as the first powered reusable stapler equipped with a Real-Time Firing Curve™ and 90-degree articulation. Unlike conventional motorized staplers that give general feedback, this innovative device offers surgeons continuous and specific information regarding tissue behavior along the stapling line, thereby enhancing precision during surgical operations.

Features and Benefits

One of the most critical focal points of the iREACH IRIS is its ability to provide real-time data on the compression forces and irregularities associated with different types of tissue. This feature is invaluable for evaluating how well the stapler is functioning under varying conditions, allowing for the identification of areas that may require closer attention throughout the stapling process.

During minimally invasive surgeries, where tactile feedback and visibility may be limited, the real-time insights from the iREACH IRIS grant surgeons a substantial advantage in making informed decisions. The platform also employs audible and visual signals during critical stages of surgery, ensuring that surgical teams receive clear cues in real time.

Furthermore, anastomotic leaks, which present a serious complication in gastrointestinal surgeries, can often be linked to variations in tissue state and suture line integrity. The real-time feedback provided by iREACH IRIS enhances the precision with which the suture line can be assessed, thereby mitigating potential complications and improving patient outcomes.

A Statement from Management

Warren Wang, the President and CEO of Genesis MedTech, remarked, “At Genesis MedTech, we strive to turn clinical needs into practical solutions. iREACH IRIS reflects this goal by advancing beyond traditional stapling methods, equipping surgeons with clearer, real-time insights into tissue behavior during procedures.”

Advanced Articulation and Accessibility

The Direction-True™ articulation translates the surgeon’s intentions directly into instrument movement, maintaining consistent control over the articulating mechanism, even when the device's jaw is rotated. Coupled with the Ultraflex™ 90 reload, the iREACH IRIS achieves articulation angles of up to 90 degrees, surpassing the typical 45 to 60 degrees provided by conventional electric staplers. This capability is essential for surgeries involving anatomical constraints, such as low anterior resection or single-port thoracic surgery, where optimal access and positioning can significantly influence surgical outcomes.

The ability to achieve better access not only supports objectives such as achieving negative resection margins but also aids in preserving sphincter function, critical to patient recovery.

Streamlined Workflow

The IRIS stapling platform has streamlined its design by making all components that come into contact with patients single-use, thus eliminating the need for re-sterilization and facilitating smoother workflow transitions between surgeries. A reusable handle with a detachable feed setup ensures ongoing availability of the device, reducing downtime due to reloading the handles. Furthermore, separating reusable and disposable components minimizes the risk of cross-contamination, which is proactively managed from the design stage rather than relying solely on post-process protocols.

By merging real-time tissue information with precise control and an optimized workflow, the iREACH IRIS represents a transformative step in motorized stapling technology aimed to promote more reliable and informed surgical performance.

About Genesis MedTech

Genesis MedTech Group, headquartered in Singapore, is a global medical device company dedicated to improving healthcare standards. The company focuses on designing and developing innovations that make treatments safer, less invasive, and more broadly accessible, ultimately aiding healthcare professionals in delivering better outcomes for their patients. With robust capacities spanning R&D, manufacturing, and marketing, Genesis MedTech is committed to maintaining quality while offering high-standard medical devices across surgical, cardiological, and vascular intervention specialties.

To learn more, visit Genesis MedTech's official site and follow us on LinkedIn.